Dusting PowderDusting Powder
Over-The-Counter (OTC)Antifungal MedicationsCode: 2639

Terbinafine Hydrochloride Dusting Powder 1%

Generic Formulation:Terbinafine Hydrochloride Dusting Powder 1% w/w
Pack Size:30g
Common Commercial Brand Equivalents:Market reference only

MRP Under Process

Official PMBI MRP is being updated for catalog code 2639.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Terbinafine Hydrochloride topical formulation is a fungicidal allylamine antifungal. It inhibits squalene epoxidase in fungal cell membranes, causing rapid fungal cell death. Highly effective against dermatophytes (Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum). Indicated for tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm).

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2639.Report inaccuracy

Usage Guidelines

Clean and thoroughly dry the affected skin area. Apply a thin layer of cream/gel once or twice daily, extending 1-2 inches beyond the active margin of the lesion. Wash hands thoroughly after application. Continue for the full prescribed duration (usually 1-2 weeks) even if symptoms resolve earlier.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Local burning, stinging, erythema, dryness, pruritus. Rare/Severe: Allergic contact dermatitis and severe localized irritation.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

For external cutaneous application only; avoid contact with eyes, nose, mouth, and mucous membranes. Discontinue if severe local sensitization develops.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.